Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00214_DB01432_nanopub.RA6_Ye8nWchHhdh4fi8XJHgvSFtO_dCAcyxyk5wqmiFeM#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00214_DB01432 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00214_DB01432 label "DDI between Torasemide and Cholestyramine - Cholestyramine may decrease the bioavailability of Torasemide by inhibiting Torasemide absorption. Monitor for changes in the therapeutic and adverse effects of Torasemide if Cholestyramine is initiated, discontinued or dose changed. Spacing administration by at least 2 hours may reduce the risk of interaction. [drugbank_resource:DB00214_DB01432]" assertion.
- drugbank_resource:DB00214_DB01432 identifier "drugbank_resource:DB00214_DB01432" assertion.
- drugbank_resource:DB00214_DB01432 title "DDI between Torasemide and Cholestyramine - Cholestyramine may decrease the bioavailability of Torasemide by inhibiting Torasemide absorption. Monitor for changes in the therapeutic and adverse effects of Torasemide if Cholestyramine is initiated, discontinued or dose changed. Spacing administration by at least 2 hours may reduce the risk of interaction." assertion.
- drugbank:DB01432 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00214_DB01432 assertion.
- drugbank:DB00214 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00214_DB01432 assertion.